15318731

Sessions DR

2004

Development of a model for inducing transient insulin resistance in the mare: preliminary implications regarding the estrous cycle.

15319822

Lockwood G

2004

The diagnostic value of inhibin in infertility evaluation.

15322594

Al-Ojaimi EH

2004

Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.

15322809

Stikkelbroeck NM

2004

Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

15326421

Brown AJ

2004

Depression and insulin resistance: applications to polycystic ovary syndrome.

15329076

El-Khayat HA

2004

Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.

15331545

Gambineri A

2004

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

15333250

Babu KA

2004

CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women.

15333252

Wang JX

2004

Risk factors for the deterioration of glucose metabolism in polycystic ovary syndrome.

15333601

Schmid J

2004

Infertility caused by PCOS--health-related quality of life among Austrian and Moslem immigrant women in Austria.

15339462

Yu J

2004

[Integrated traditional Chinese and western medicine should make new contribution to the reproductive health of women].

15341255

Mitkov M

2004

[Combined use of metformin and Diane35 in polycystic ovary syndrome].

15341262

Pekhlivanov B

2004

[Contemporary diagnostic criteria for polycystic ovary syndrome].

15350255

Mitwally MF

2004

Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.

15353300

Goldman S

2004

MMPS and TIMPS in ovarian physiology and pathophysiology.

15354503

Murray R

2004

Polycystic ovary syndrome, obesity and insulin resistance: the new female triad.

15356029

Ib??ez L

2004

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

15356031

Adams JM

2004

Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.

15356067

Orio F Jr

2004

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.

15356085

Ib??ez L

2004

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

15356308

Yki-J?rvinen H

2004

Thiazolidinediones.

15358717

Kashyap S

2004

Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.

15358718

Yu Ng EH

2004

Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation.

15358722

Petermann TS

2004

Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.

15363349

Zhu WJ

2004

[Outcome of follicular aspiration of selection phase in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation].

15363691

Practice Committee of the American Society for Reproductive Medicine.

2004

Current evaluation of amenorrhea.

15363722

Practice Committee of the American Society for Reproductive Medicine.

2004

Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.

15366661

Orbetzova MM

2003

Metabolic disturbances in women with polycystic ovary syndrome.

15366662

Orbetzova MM

2003

Role of 24-hour monitoring in assessing blood pressure changes in polycystic ovary syndrome.

15374711

Carmina E

2004

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.

15374726

Heinonen S

2004

The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome.

15374729

Tartagni M

2004

Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

15374736

Lechin F

2004

Neuroendocrine profiling in PCOS.

15379296

Morrell MJ

2004

Reproductive disturbances in patients with epilepsy.

15379300

Penovich PE

2004

Recommendations for the care of women with epilepsy.

15379332

Devoto E

2004

[Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women].

15380140

Hart R

2004

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.

15380141

Balen A

2004

The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.

15380142

Amato P

2004

The genetics of polycystic ovary syndrome.

15380143

Moran L

2004

Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.

15380144

Archer JS

2004

Hirsutism and acne in polycystic ovary syndrome.

15380145

van der Spuy ZM

2004

The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome.

15380146

Homburg R

2004

Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome.

15380147

Farquhar CM

2004

The role of ovarian surgery in polycystic ovary syndrome.

15380148

Cattrall FR

2004

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.

15380149

Fraser IS

2004

Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome.

15388683

Muth S

2004

Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements?

15425567

INGERSOLL FM

1950

Bilateral polycystic ovaries, Stein-Leventhal syndrom.

15446290

Hormone Foundation.

2004

Patient information page. Polycystic ovary syndrome.

15450011

Singh R

2004

Epidemiology of childhood type 2 diabetes in the developing world.

15451566

Laven JS

2004

Inhibins and adult ovarian function.

15461558

Yildiz BO

2004

Recent advances in the treatment of polycystic ovary syndrome.

15462547

Z?rate A

2004

[Current criterion for diagnosing polycystic ovary syndrome].

15464424

Meirhaeghe A

2004

Impact of genetic variation of PPARgamma in humans.

15464773

Beigi A

2004

Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.

15464783

Ari? WM

2004

Effects of finasteride on the morphology of polycystic ovaries.

15467530

Chang RJ

2004

A practical approach to the diagnosis of polycystic ovary syndrome.

15472165

Norman RJ

2004

Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome.

15472166

Palomba S

2004

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

15472207

Schneyer AL

2004

Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay.

15472214

Orio F Jr

2004

Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.

15474095

Izquierdo D

2004

Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis.

15474880

Sir-Petermann T

2004

Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load.

15475228

Greenfield JR

2004

Insulin resistance and obesity.

15481036

Karadeniz NN

2004

Is SHORT syndrome another phenotypic variation of PITX2?

15481485

Karoshi M

2004

Commentary: Polycystic ovarian disease (PCOD): a misnomer, looking for a new name.

15482002

Wiegratz I

2004

Long-cycle treatment with oral contraceptives.

15482755

F?bregues F

2004

Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.

15482765

Baillargeon JP

2004

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

15482785

La Marca A

2004

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.

15482786

Kahsar-Miller M

2004

Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.

15483098

Orio F Jr

2005

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.

15483105

Ib??ez L

2005

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.

15483106

Sepilian V

2005

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.

15486238

Tanaka YO

2004

Functioning ovarian tumors: direct and indirect findings at MR imaging.

15486819

Ferrero S

2004

Active ghrelin levels in women with polycystic ovary syndrome.

15489238

Fisher S

2005

Falling estradiol levels as a result of intentional reduction in gonadotrophin dose are not associated with poor IVF outcomes, whereas spontaneously falling estradiol levels result in low clinical pregnancy rates.

15493567

Tok EC

2004

The androgenic profile of women with non-insulin-dependent diabetes mellitus.

15496601

Palomba S

2004

Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?

15497018

Glueck CJ

2004

Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.

15497495

Jahanfar S

2004

Leptin and its association with polycystic ovary syndrome: a twin study.

15498180

Zhang YW

2004

[Current concept of polycystic ovary syndrome].

15498181

Wu XK

2004

[Summary of the national symposium on polycystic ovary syndrome].

15498182

Chen ZJ

2004

[Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].

15498183

Liu ZA

2004

[Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].

15498184

Yao LQ

2004

[Correlation between local hormones and CD36 transcription level in women with polycystic ovary].

15498185

Qiu Y

2004

[Ultrasound criterion for the diagnosis of polycystic ovary syndrome: ovarian stroma/total area ratio].

15505757

Unluhizarci K

2004

A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.

15507511

Goodarzi MO

2005

beta-Cell function: a key pathological determinant in polycystic ovary syndrome.

15507516

Ehrmann DA

2005

Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

15509089

Schmid J

2004

Psychosocial and sociocultural aspects of infertility--a comparison between Austrian women and immigrant women.

15511336

L?pez E

2004

Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.

15511349

Ozturk O

2004

Drug intervention in early pregnancy after assisted reproductive technology.

15511959

Rosina B

1997

The effects of somatostatin in the polycystic ovary syndrome.

15511960

Falsetti L

1997

Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome.

15513294

Schr?der AK

2004

Insulin resistance in patients with polycystic ovary syndrome.

15513972

Seow KM

2005

Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.

15513975

S?nmez AS

2005

Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.

15514033

Nelson-Degrave VL

2005

Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.

15516780

Tarkun I

2004

The plasminogen activator system in young and lean women with polycystic ovary syndrome.